カテゴリー： Market Monitor Global, 世界, 医療/バイオ

10価肺炎球菌結合型ワクチンの世界市場見通し2023年-2029年

◆英語タイトル：10-Valent Pneumococcal Polysaccharide Vaccine Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8767 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：70 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global 10-Valent Pneumococcal Polysaccharide Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるの10価肺炎球菌結合型ワクチン市場規模と予測を収録しています。・世界の10価肺炎球菌結合型ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界の10価肺炎球菌結合型ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の10価肺炎球菌結合型ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「単回投与バイアル」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

10価肺炎球菌結合型ワクチンのグローバル主要企業は、GSKなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、10価肺炎球菌結合型ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の10価肺炎球菌結合型ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界の10価肺炎球菌結合型ワクチン市場：タイプ別市場シェア、2022年
・単回投与バイアル、プレフィルドシリンジ

世界の10価肺炎球菌結合型ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界の10価肺炎球菌結合型ワクチン市場：用途別市場シェア、2022年
・病院、クリニック

世界の10価肺炎球菌結合型ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界の10価肺炎球菌結合型ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における10価肺炎球菌結合型ワクチンのグローバル売上、2018年-2023年
・主要企業における10価肺炎球菌結合型ワクチンのグローバル売上シェア、2022年
・主要企業における10価肺炎球菌結合型ワクチンのグローバル販売量、2018年-2023年
・主要企業における10価肺炎球菌結合型ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
GSK

*************************************************************

・調査・分析レポートの概要
10価肺炎球菌結合型ワクチン市場の定義
市場セグメント
世界の10価肺炎球菌結合型ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の10価肺炎球菌結合型ワクチン市場規模
世界の10価肺炎球菌結合型ワクチン市場規模：2022年 VS 2029年
世界の10価肺炎球菌結合型ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの10価肺炎球菌結合型ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の10価肺炎球菌結合型ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：単回投与バイアル、プレフィルドシリンジ
10価肺炎球菌結合型ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック
10価肺炎球菌結合型ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別10価肺炎球菌結合型ワクチン市場規模 2022年と2029年
地域別10価肺炎球菌結合型ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK
...

Pneumococcal conjugate 10-valent vaccine – consisting of 1 microgram of polysaccharide for serotypes 1, 5, 6B, 7F, 9V, 14 and 23F, and 3 micrograms of serotypes 4, 18C and 19F.
This report aims to provide a comprehensive presentation of the global market for 10-Valent Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 10-Valent Pneumococcal Polysaccharide Vaccine. This report contains market size and forecasts of 10-Valent Pneumococcal Polysaccharide Vaccine in global, including the following market information:
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five 10-Valent Pneumococcal Polysaccharide Vaccine companies in 2022 (%)
The global 10-Valent Pneumococcal Polysaccharide Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Single Dose Vial Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine include GSK. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, by Type, 2022 (%)
Single Dose Vial
Pre-filled Syringe
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 10-Valent Pneumococcal Polysaccharide Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies 10-Valent Pneumococcal Polysaccharide Vaccine revenues share in global market, 2022 (%)
Key companies 10-Valent Pneumococcal Polysaccharide Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies 10-Valent Pneumococcal Polysaccharide Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Outline of Major Chapters:
Chapter 1: Introduces the definition of 10-Valent Pneumococcal Polysaccharide Vaccine, market overview.
Chapter 2: Global 10-Valent Pneumococcal Polysaccharide Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of 10-Valent Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global 10-Valent Pneumococcal Polysaccharide Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 10-Valent Pneumococcal Polysaccharide Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Overall Market Size
2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2022 VS 2029
2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top 10-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market
3.2 Top Global 10-Valent Pneumococcal Polysaccharide Vaccine Companies Ranked by Revenue
3.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies
3.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies
3.5 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 10-Valent Pneumococcal Polysaccharide Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers 10-Valent Pneumococcal Polysaccharide Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 10-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market
3.8.1 List of Global Tier 1 10-Valent Pneumococcal Polysaccharide Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 10-Valent Pneumococcal Polysaccharide Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Markets, 2022 & 2029
4.1.2 Single Dose Vial
4.1.3 Pre-filled Syringe
4.2 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
4.2.1 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2023
4.2.2 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2024-2029
4.2.3 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
4.3.1 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2023
4.3.2 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2024-2029
4.3.3 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
5.2.1 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2023
5.2.2 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2024-2029
5.2.3 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
5.3.1 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2023
5.3.2 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2024-2029
5.3.3 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2022 & 2029
6.2 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
6.2.1 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2023
6.2.2 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2024-2029
6.2.3 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
6.3.1 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2023
6.3.2 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2024-2029
6.3.3 By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029
6.4.2 By Country – North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2029
6.4.3 US 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.4.4 Canada 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.4.5 Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2029
6.5.3 Germany 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.4 France 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.5 U.K. 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.6 Italy 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.7 Russia 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.5.9 Benelux 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2029
6.6.3 China 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.4 Japan 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.5 South Korea 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.6.7 India 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029
6.7.2 By Country – South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2029
6.7.3 Brazil 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.7.4 Argentina 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales, 2018-2029
6.8.3 Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8.4 Israel 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
6.8.6 UAE 10-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Major Product Offerings
7.1.4 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
8 Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, Analysis
8.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, 2018-2029
8.2 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 10-Valent Pneumococcal Polysaccharide Vaccine Supply Chain Analysis
10.1 10-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
10.2 10-Valent Pneumococcal Polysaccharide Vaccine Upstream Market
10.3 10-Valent Pneumococcal Polysaccharide Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 10-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of 10-Valent Pneumococcal Polysaccharide Vaccine in Global Market
Table 2. Top 10-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers 10-Valent Pneumococcal Polysaccharide Vaccine Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers 10-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 9. List of Global Tier 1 10-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 10-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Units), 2024-2029
Table 46. GSK Company Summary
Table 47. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product Offerings
Table 48. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global 10-Valent Pneumococcal Polysaccharide Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global 10-Valent Pneumococcal Polysaccharide Vaccine Production by Region, 2018-2023 (K Units)
Table 53. Global 10-Valent Pneumococcal Polysaccharide Vaccine Production by Region, 2024-2029 (K Units)
Table 54. 10-Valent Pneumococcal Polysaccharide Vaccine Market Opportunities & Trends in Global Market
Table 55. 10-Valent Pneumococcal Polysaccharide Vaccine Market Drivers in Global Market
Table 56. 10-Valent Pneumococcal Polysaccharide Vaccine Market Restraints in Global Market
Table 57. 10-Valent Pneumococcal Polysaccharide Vaccine Raw Materials
Table 58. 10-Valent Pneumococcal Polysaccharide Vaccine Raw Materials Suppliers in Global Market
Table 59. Typical 10-Valent Pneumococcal Polysaccharide Vaccine Downstream
Table 60. 10-Valent Pneumococcal Polysaccharide Vaccine Downstream Clients in Global Market
Table 61. 10-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. 10-Valent Pneumococcal Polysaccharide Vaccine Segment by Type in 2022
Figure 2. 10-Valent Pneumococcal Polysaccharide Vaccine Segment by Application in 2022
Figure 3. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by 10-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2022
Figure 9. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit), 2018-2029
Figure 13. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit), 2018-2029
Figure 17. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 23. US 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 28. Germany 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 37. China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production 10-Valent Pneumococcal Polysaccharide Vaccine by Region, 2022 VS 2029
Figure 54. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
Figure 55. Marketing Channels

※参考情報

10価肺炎球菌結合型ワクチンは、肺炎球菌による感染症を予防するために開発されたワクチンの一種です。肺炎球菌は、特に小児や高齢者において重篤な病気を引き起こす原因となる細菌であり、肺炎、中耳炎、髄膜炎などの疾患を引き起こします。このワクチンは、特定の10種類の肺炎球菌株に対して免疫応答を誘導することを目的としています。

まず、このワクチンの定義について説明します。結合型ワクチンとは、肺炎球菌の多糖体をキャリアタンパク質に結合させることで、免疫系がより強力に反応するように設計されています。この結合によって、特に幼児や免疫力が低下している人々に対しても効果的な免疫反応を引き起こします。10価という名称は、このワクチンが10種類の異なる肺炎球菌の多糖体を含んでいることを示しています。

特徴的な点として、自発的に抗体を産生する能力が高まることが挙げられます。結合型ワクチンは、単純な多糖体ワクチンと比較して、細胞性免疫を促進することが可能です。これにより、より持続的かつ強力な免疫応答が得られるため、長期にわたる感染防御が期待できます。

このワクチンの種類について説明すると、10価肺炎球菌結合型ワクチンは、主に小児に対する予防接種プログラムで使用されています。各国の健康政策に応じて、ワクチン接種の対象年齢や回数が異なります。通常、初回接種は生後2ヶ月から開始され、数回の追加接種が推奨されています。また、このワクチンは成人にも投与されることがありますが、通常は他の種類の肺炎球菌ワクチンと併用されることが多いです。

用途としては、主に以下のような疾患に対する予防が挙げられます。肺炎球菌感染症は、特に小児の急性中耳炎や肺炎の主要な原因であり、高齢者の肺炎や髄膜炎にも関与しています。そのため、このワクチンは特にリスクの高い集団での疫病予防に重要な役割を果たしています。また、肺炎球菌感染症の流行を防ぐことで、社会全体の公衆衛生の向上にも寄与しています。

関連技術としては、免疫学や生物工学の進展があります。結合型ワクチンの製造には、先進的な精製技術やキャリアタンパク質の開発が必要です。これにより、ワクチンの安全性や効果が向上し、接種後のアレルギー反応などのリスクを低減することが可能となっています。また、遺伝子工学を用いた新しいタイプのワクチン開発も進行中であり、今後のさらなる改良が期待されています。

近年、10価肺炎球菌結合型ワクチンの接種が推奨される理由として、集団免疫の重要性が挙げられます。多くの人々がワクチン接種を受けることで、感染症の広がりを抑制し、特に免疫系が弱い人々に対しての保護が強化されます。これにより、社会全体の感染症の負担が軽減されることが期待されています。

また、ワクチンの開発や普及に伴い、経済的な影響も大きな要素となります。肺炎球菌感染症による病院での治療費用や入院期間を考慮すると、予防ワクチンの接種によって得られる経済的利益が明らかです。特に、感染が重篤化する前に予防することが、医療資源を効率的に活用するためにも重要です。

10価肺炎球菌結合型ワクチンは、その効果的な予防措置としての役割から、多くの国で広く使用されています。これにより、肺炎球菌による感染症の発症率は著しく低下しており、公衆衛生政策においても重要な位置を占めています。ただし、ワクチン接種による免疫が持続する期間や、新興の肺炎球菌株への対応など、今後の研究が必要な課題も残されています。

最終的に、肺炎球菌による感染症は今後も重要な健康問題であり続けるため、10価肺炎球菌結合型ワクチンを含む予防策の継続的な実施が求められます。医療従事者や公衆衛生専門家は、ワクチンの重要性を広める必要があり、特に対象となる集団への接種率向上を目指す努力が必要です。またワクチンを通じて感染症予防や健康維持が進められることで、社会全体の健康水準が向上することが期待されます。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 10価肺炎球菌結合型ワクチンの世界市場見通し2023年-2029年(10-Valent Pneumococcal Polysaccharide Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

10価肺炎球菌結合型ワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp